These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 3301365)
1. Immunotherapy of xenografted human bladder cancer in nude mice using monoclonal antibody. Yu DS; Yeh MY; Chang SY; Ma CP; Han SH Eur Urol; 1987; 13(3):198-202. PubMed ID: 3301365 [TBL] [Abstract][Full Text] [Related]
2. Radioimmunotherapy of xenografted human bladder cancer using monoclonal antibody against blood group A-related antigen. Yeh MY; Yu DS; Chang SY; Ma CP; Han SH Eur Urol; 1988; 14(5):386-90. PubMed ID: 3169082 [TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies for intravesical radioimmunotherapy of human bladder cancer. Russell PJ; Plomley J; Shon IH; O'Grady H; Pearce N Cell Biophys; 1993; 22(1-3):27-47. PubMed ID: 7889541 [TBL] [Abstract][Full Text] [Related]
4. Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma. Inoue K; Slaton JW; Perrotte P; Davis DW; Bruns CJ; Hicklin DJ; McConkey DJ; Sweeney P; Radinsky R; Dinney CP Clin Cancer Res; 2000 Dec; 6(12):4874-84. PubMed ID: 11156247 [TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of doxorubicin-monoclonal antibody conjugate on human bladder cancer. Yu DS; Chu TM; Yeh MY; Chang SY; Ma CP; Han SH J Urol; 1988 Aug; 140(2):415-21. PubMed ID: 3398165 [TBL] [Abstract][Full Text] [Related]
7. A cytotoxic monoclonal antibody produced from a human urinary bladder carcinoma cell line (TSGH-8301). Ma CP; Yeh MY; Yu DS; Jiang SY; Wang CC; Chang SY; Han SH Proc Natl Sci Counc Repub China B; 1988 Apr; 12(2):101-8. PubMed ID: 3054971 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies against human urinary bladder carcinomas: selectivity and utilization for gamma scintigraphy. Bubeńik J; Kieler J; Perlmann P; Paulie S; Koho H; Christensen B; Dienstbier Z; Koprivová H; Pospísil J; Poucková P Eur J Cancer Clin Oncol; 1985 Jun; 21(6):701-10. PubMed ID: 3894033 [TBL] [Abstract][Full Text] [Related]
9. Production and characterization of monoclonal antibodies to the established human bladder cancer cell lines. Sasaki M Keio J Med; 1984 Apr; 33(1):39-56. PubMed ID: 6384610 [No Abstract] [Full Text] [Related]
10. In vivo localisation of human urinary bladder carcinoma xenograft in nude mice using radiolabelled monoclonal antibody. Yü DS; Yeh MY; Chen WL; Chang SY; Ma CP; Han SH Br J Urol; 1987 Jun; 59(6):540-6. PubMed ID: 3690186 [TBL] [Abstract][Full Text] [Related]
11. [Characterization of a novel transplantable orthotopic nude mouse model with xenografted human bladder transitional cell tumor (BIU-87)]. Li C; Yan RP; Yuan GH; Feng YG; Wang JS; Gao X; Huang YS; Zhou JB; Xie SS Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):733-6. PubMed ID: 17366782 [TBL] [Abstract][Full Text] [Related]
12. Human transitional cell carcinoma in the NMRI-nu/nu mouse bladder: a new animal model for the in vivo use of monoclonal antibodies and cytotoxic agents. Huland E; Arndt R; Huland H Cancer Res; 1986 May; 46(5):2488-9. PubMed ID: 3697989 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antiidiotypic antibodies related to a murine oncofetal bladder tumor antigen induce specific cell-mediated tumor immunity. Lee VK; Harriott TG; Kuchroo VK; Halliday WJ; Hellström I; Hellström KE Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6286-90. PubMed ID: 3875859 [TBL] [Abstract][Full Text] [Related]
14. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II). Mizutani Y; Yoshida O; Bonavida B J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929 [TBL] [Abstract][Full Text] [Related]
15. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors. Scott AM; Geleick D; Rubira M; Clarke K; Nice EC; Smyth FE; Stockert E; Richards EC; Carr FJ; Harris WJ; Armour KL; Rood J; Kypridis A; Kronina V; Murphy R; Lee FT; Liu Z; Kitamura K; Ritter G; Laughton K; Hoffman E; Burgess AW; Old LJ Cancer Res; 2000 Jun; 60(12):3254-61. PubMed ID: 10866319 [TBL] [Abstract][Full Text] [Related]
16. A monoclonal antibody to human transitional cell carcinoma of the bladder: production and characterization. Takahashi N; Takahashi S; Takahashi K; Suzuki T; Funyu T J Urol; 1987 Jul; 138(1):207-11. PubMed ID: 2439711 [TBL] [Abstract][Full Text] [Related]
17. Long term protection in bladder cancer following intralesional immunotherapy. Reichert DF; Lamm DL J Urol; 1984 Sep; 132(3):570-3. PubMed ID: 6381762 [TBL] [Abstract][Full Text] [Related]
18. The expression of epidermal growth factor receptor on human bladder cancer: potential use in radioimmunoscintigraphy. Harney JV; Liebert M; Wedemeyer G; Washington R; Stein J; Buchsbaum D; Steplewski Z; Grossman HB J Urol; 1991 Jul; 146(1):227-31. PubMed ID: 2056595 [TBL] [Abstract][Full Text] [Related]
19. [Production and characterization of a group of monoclonal antibodies to human transitional cell carcinoma]. Guo YL Zhonghua Wai Ke Za Zhi; 1992 Nov; 29(12):777-80, 799-800. PubMed ID: 1618045 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to two mouse bladder carcinoma antigens. Hellström I; Rollins N; Settle S; Chapman P; Chapman WH; Hellström KE Int J Cancer; 1982 Feb; 29(2):175-80. PubMed ID: 7037659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]